Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Vaccine|February 17, 2025
Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)Mónica S Sierra, Loretto J Carvajal, Peter Dull, et al.
Nature Communications|February 21, 2024
Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infectionGathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, et al.
International Journal of Cancer|March 13, 1999
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11T Luostarinen, V af Geijersstam, T Bjørge, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)S K Kjaer, B Chackerian, A J van den Brule, et al.
Plos One|March 19, 2015
Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedlesRhonda C Kines, Vladimir Zarnitsyn, Teresa R Johnson, et al.
Molecular Cancer Therapeutics|December 16, 2017
An Infrared Dye-Conjugated Virus-like Particle for the Treatment of Primary Uveal MelanomaRhonda C Kines, Isabella Varsavsky, Sanghamitra Choudhary, et al.
The Journal of Infectious Diseases|October 9, 1999
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesionsL Wideroff, M Schiffman, P Haderer, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2025
Mouse Papillomavirus Outbreak in a Research FacilityKristin E Killoran, Matthew W Breed, Melody E Roelke-Parker, et al.
Vaccine|May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypesKirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Journal of the National Cancer Institute|February 22, 2001
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccineC D Harro, Y Y Pang, R B Roden, et al.
Pageof 28